MED15 involved in head and neck squamous cell carcinoma

April 2, 2015
MED15 involved in head and neck squamous cell carcinoma

(HealthDay)—The mediator subunit MED15 appears to be involved in head and neck squamous cell carcinoma (HNSCC), according to a study published in the April issue of The American Journal of Pathology.

Zaki Shaikhibrahim from the University Hospital of Bonn in Germany, and colleagues examined the role of MED15 in HNSCC. They performed immunohistochemistry for MED15 on 324 tissue samples. MED15 knockdown was also performed, followed by proliferation and migration assays, as was transforming growth factor-β-1 (TGF-β1) treatment followed by MED15 analysis.

The researchers found that MED15 was overexpressed in 35, 30, and 70 percent of primary tumors, lymph node metastases, and recurrences, respectively, compared with no or low expression in . In primary tumors from patients who developed recurrences, MED15 overexpression correlated with elevated mortality rates and was seen at the highest frequency in oral cavity or oropharyngeal tumors. There was a correlation for MED15 expression between primary tumors and corresponding . TGF-β activity in tissues was associated with MED15; TGFβ activation led to increased MED15 expression and decreased pSMAD3 on MED15 knockdown.

"Taken together, our results implicate MED15 in HNSCC and hint that MED15 overexpression is a clonal event during HNSCC progression," the authors write. "MED15 may serve as a for recurrence and as a therapeutic target."

Explore further: Researchers ID potential prognostic marker for recurrence of head and neck squamous cell carcinoma

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Researchers ID potential prognostic marker for recurrence of head and neck squamous cell carcinoma

March 20, 2015
A new study provides the first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC). MED15 overexpression was found to be associated ...

Periodontitis linked to HPV-positive head, neck tumors

June 20, 2012
(HealthDay) -- For patients with head and neck squamous cell carcinoma (HNSCC) there is an increased risk of human papillomavirus (HPV)-positive tumors among those with a history of periodontitis, according to a study published ...

Sensitizing tumor cells to radiotherapy

March 1, 2012
Head and neck squamous cell carcinoma (HNSCC) is the fifth most common cancer worldwide. Tumor resistance to radio- and/or chemotherapy remains a significant clinical problem.

New radiotracer helps avoid neck dissection in patients with early head and neck cancer

February 13, 2015
The discovery that the identification and biopsy of the first lymph node to which a cancer spreads (the sentinel node) can lead to more accurate diagnosis and treatment has revolutionised the management of breast cancer. ...

Comprehensive genomic analysis identifies alterations in head and neck cancer that could lead to targeted therapy

April 8, 2013
Not all head and neck squamous cell carcinomas (HNSCCs) have the same pattern of genomic alterations, but those cancers with certain distinctive patterns could be amenable to specific targeted therapies, according to a researcher ...

Recommended for you

Scientists sharpen the edges of cancer chemotherapy with CRISPR

July 13, 2018
Tackling unsolved problems is a cornerstone of scientific research, propelled by the power and promise of new technologies. Indeed, one of the shiniest tools in the biomedical toolkit these days is the genome editing system ...

Looking at the urine and blood may be best in diagnosing myeloma

July 13, 2018
When it comes to diagnosing a condition in which the plasma cells that normally make antibodies to protect us instead become cancerous, it may be better to look at the urine as well as the serum of our blood for answers, ...

Massive genome havoc in breast cancer is revealed

July 12, 2018
In cancer cells, genetic errors wreak havoc. Misspelled genes, as well as structural variations—larger-scale rearrangements of DNA that can encompass large chunks of chromosomes—disturb carefully balanced mechanisms that ...

Study shows biomarker panel boosts lung cancer risk assessment for smokers

July 12, 2018
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon smoking history, capturing risk for people who have ever smoked, not only for heavy smokers, an international ...

Discovering the mechanisms that underlie prostate cancer

July 12, 2018
New research has uncovered insights into the mechanisms that underlie prostate cancer, providing potential targets for new cancer therapies.

New method reveals how well cancer drugs hit their targets

July 12, 2018
Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumour in real time, revealing which cells interact with the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.